Table 1 Demographic data and clinical characteristics of controls and ACLF patients

Age (yr)

42.54 ± 8.65

45.68 ± 5.39

45.23 ± 9.32

47.52 ± 11.88

Sex(M/F)

24/6

24/6

24/6

103/21

PT (%)

84.58 ± 15.77

76.36 ± 16.87

45.12 ± 11.27

37.76 ± 14.54*^#

Fb (g/L)

2.68 ± 0.67

2.23 ± 0.95

1.65 ± 0.51

1.56 ± 0.71*^#

INR

1.21 ± 0.19

1.37 ± 0.21

2.12 ± 0.34

2.09 ± 0.69*^#

WBC(1 × 10⁹/L)

5.68 ± 1.54

4.85 ± 1.75

15.56 ± 6.45

14.46 ± 8.47*^#

PLT (1 × 10⁹/L)

225.97 ± 38.54

115.04 ± 58.21

130.21 ± 21.35

99.90 ± 61.41*^#

ALT (U/L)

25.21 ± 12.31

25.81 ± 12.32

355.75 ± 301.25

288.69 ± 396.73*^#

GLU (mM)

4.39 ± 0.68

4.54 ± 0.98

5.23 ± 2.56

5.83 ± 3.32*^#

TBIL (μM)

13.22 ± 3.79

19.88 ± 7.98

299.32 ± 178.23

320.62 ± 136.81*^#

CHOL (mM)

3.97 ± 0.69

3.45 ± 0.91

2.78 ± 0.56

2.58 ± 0.90*^#

CREA (μM)

49.67 ± 11.21

57.61 ± 9.81

65.23 ± 16.56

66.09 ± 22.22*^#

MELD

25.05 ± 4.89

25.16 ± 4.33